×
Zealand Pharma Net Profit Margin 2017-2025 | ZLDPF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Zealand Pharma net profit margin from 2017 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Zealand Pharma Net Profit Margin 2017-2025 | ZLDPF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Zealand Pharma net profit margin from 2017 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$226.4B
Amgen (AMGN)
$166.3B
Gilead Sciences (GILD)
$141.3B
Vertex Pharmaceuticals (VRTX)
$122.5B
Bristol Myers Squibb (BMY)
$99.7B
CSL (CSLLY)
$85.2B
GSK (GSK)
$77.9B
Regeneron Pharmaceuticals (REGN)
$61.8B
Alnylam Pharmaceuticals (ALNY)
$42.5B
Argenex SE (ARGX)
$35.2B
BioNTech SE (BNTX)
$27.5B
Royalty Pharma (RPRX)
$20.2B
Insmed (INSM)
$19.6B
Biogen (BIIB)
$19.2B
Illumina (ILMN)
$16.6B
Genmab (GNMSF)
$14.9B
Genmab (GMAB)
$14.7B
Incyte (INCY)
$13.7B
Moderna (MRNA)
$13.4B
Exelixis (EXEL)
$12.4B
BioMarin Pharmaceutical (BMRN)
$11.4B
QIAGEN (QGEN)
$11.2B
Swedish Orphan Biovitrum (BIOVF)
$10.6B
Ascendis Pharma (ASND)
$10.4B
Exact Sciences (EXAS)
$9.1B
Verona Pharma American Depositary Share (VRNA)
$8.9B
Bio-Techne Corp (TECH)
$8.7B
Blueprint Medicines (BPMC)
$8.3B
Legend Biotech (LEGN)
$8.1B
Roivant Sciences (ROIV)
$7.7B